Orchard Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ORTX and buy or sell other stocks, ETFs, and their options commission-free!About ORTX
Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies.
CEOBobby Gaspar
CEOBobby Gaspar
Employees259
Employees259
HeadquartersLondon, Greater London
HeadquartersLondon, Greater London
Founded2018
Founded2018
Employees259
Employees259
ORTX Key Statistics
Market cap2.12B
Market cap2.12B
Price-Earnings ratio-0.41
Price-Earnings ratio-0.41
Dividend yield—
Dividend yield—
Average volume728.34K
Average volume728.34K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.8875
52 Week high$0.8875
52 Week low$0.3601
52 Week low$0.3601
Stock Snapshot
The current Orchard Therapeutics(ORTX) stock price is $16.70, with a market capitalization of 2.12B. The stock trades at a price-to-earnings (P/E) ratio of -0.41.
On 2025-12-18, Orchard Therapeutics(ORTX) stock opened at —, reached a high of —, and a low of —.
The Orchard Therapeutics(ORTX)'s current trading volume is 0, compared to an average daily volume of 728.34K.
During the past year, Orchard Therapeutics(ORTX) stock moved between $0.36 at its lowest and $0.89 at its peak.
During the past year, Orchard Therapeutics(ORTX) stock moved between $0.36 at its lowest and $0.89 at its peak.